Alessandro Perrella: It is Not Only about “How High the CRP is”, but “in Which Patient” We are Measuring That Value
Alessandro Perrella, Director of the Unit of Emerging and Highly Contagious Infectious Diseases at Ospedali dei Colli, Infectious Disease Specialist at Antonio Cardarelli National Referral Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Antibiotics, adding:
“In a panorama where we often look for a single, linear answer, this study conducted in the Department of Infectious Diseases and Emerging Infectious Diseases shows that even a key parameter like PCR and CRP can lose its meaning if we do not take into account the ‘background noise’ generated by chronic inflammatory comorbidities.
In other words, it is not only about ‘how high the CRP is’, but ‘in which patient’ we are measuring that value.
From this perspective, we developed a ‘Comorbidity Confounder Score‘ (CCS), built on physiopathological grounds, which isolates the subgroups in which CRP regains a good ability to distinguish bacterial from viral infections, while still remaining an exploratory tool that has not yet been validated for clinical use.
The paper published yesterday in Antibiotics also presents a prototype of a ‘POC‑CRP Assistant‘, a web app that automates CCS calculation and provides a contextualized interpretation of CRP values, designed to integrate with new point‑of‑care (POC) systems and ward workflows.
This is only the beginning of a journey toward integrating AI‑based tools into clinical practice, but it is important to start precisely by recognizing ‘visible’ confounders and building simple, transparent solutions that are integrated into everyday practice.
The goal is not to replace clinicians, but to support them in making more informed decisions.
A huge thank you to the entire working group, without whom all this would have been impossible: Prof. Paola Salvatore, Francesca Futura Bernardi, Pierpaolo Di Micco, Ugo Trama, Rita Boenzi, Antimo di Spirito, Claudia Tiberio, Giusy di Flumeri, Nicolina Capoluongo and Mariano Bernardo.
Stay tuned:
We will be back with new amazing AI‑based strategies in Infectious Disease.”
Title: The Confounder in Plain Sight: A Retrospective Pilot Analysis on the Impact of Comorbidity on C-Reactive Protein Utility for Differentiating Bacterial vs. Viral Infections
Authors: Alessandro Perrella, Paola Salvatore, Pierpaolo Di Micco, Ugo Trama, Antimo Di Spirito, Claudia Tiberio, Mariano Bernardo, Nicolina Capoluongo, Giusy Di Flumeri, Rita Boenzi, Francesca Futura Bernardi

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 14:42Bruno Pougault: The Global Momentum Behind Innovation in Thrombosis and Hemostasis
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026